COMBINATION THERAPY USING C-C CHEMOKINE RECEPTOR 4 (CCR4) ANTAGONISTS AND ONE OR MORE IMMUNE CHECKPOINT INHIBITORS

• 收藏
• 分享

专利权人:

CHEMOCENTRYX; INC.

发明人:

Shijie LI,Venkat Reddy MALI,Rajinder SINGH,Ju YANG,Penglie ZHANG

申请号：

US16553339

公开号：

US20200069673A1

申请日:

2019.08.28

申请国别(地区):

US

年份:

2020

代理人:

摘要：

The present disclosure is drawn to the combination therapy of a C—；C Chemokine Receptor 4 (CCR4) antagonist and one or more immune checkpoint inhibitors in the treatment of cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/